drugset / Trial / NCT05552625
The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
This study will assess the safety and efficacy and tolerability of TADIOS compared to placebo in patients with mild to moderate COVID-19.
Timeline
- Start
- 2021-05-06
- Primary completion
- 2022-02-24
- Completion
- 2022-02-24
Outcome
Outcome not reported
Stopped: “This Phase I study was conducted in India and no subject data was provided to sponsor.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TADIOS | Traditional medicine (herbal / TCM) | 1200 mg | — |